PAHC Relative Valuation
PAHC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PAHC is overvalued; if below, it's undervalued.
Historical Valuation
Phibro Animal Health Corp (PAHC) is now in the Undervalued zone, suggesting that its current forward PE ratio of 14.84 is considered Undervalued compared with the five-year average of 13.69. The fair price of Phibro Animal Health Corp (PAHC) is between 51.01 to 65.18 according to relative valuation methord. Compared to the current price of 41.62 USD , Phibro Animal Health Corp is Undervalued By 18.42%.
Relative Value
Fair Zone
51.01-65.18
Current Price：41.62
18.42%
Undervalued
14.61
PE
1Y
3Y
5Y
Trailing
Forward
9.97
EV/EBITDA
Phibro Animal Health Corp. (PAHC) has a current EV/EBITDA of 9.97. The 5-year average EV/EBITDA is 9.14. The thresholds are as follows: Strongly Undervalued below 5.89, Undervalued between 5.89 and 7.51, Fairly Valued between 10.76 and 7.51, Overvalued between 10.76 and 12.39, and Strongly Overvalued above 12.39. The current Forward EV/EBITDA of 9.97 falls within the Historic Trend Line -Fairly Valued range.
11.98
EV/EBIT
Phibro Animal Health Corp. (PAHC) has a current EV/EBIT of 11.98. The 5-year average EV/EBIT is 12.29. The thresholds are as follows: Strongly Undervalued below 8.73, Undervalued between 8.73 and 10.51, Fairly Valued between 14.07 and 10.51, Overvalued between 14.07 and 15.85, and Strongly Overvalued above 15.85. The current Forward EV/EBIT of 11.98 falls within the Historic Trend Line -Fairly Valued range.
1.14
PS
Phibro Animal Health Corp. (PAHC) has a current PS of 1.14. The 5-year average PS is 0.77. The thresholds are as follows: Strongly Undervalued below 0.30, Undervalued between 0.30 and 0.54, Fairly Valued between 1.01 and 0.54, Overvalued between 1.01 and 1.25, and Strongly Overvalued above 1.25. The current Forward PS of 1.14 falls within the Overvalued range.
10.56
P/OCF
Phibro Animal Health Corp. (PAHC) has a current P/OCF of 10.56. The 5-year average P/OCF is 4.46. The thresholds are as follows: Strongly Undervalued below -5.02, Undervalued between -5.02 and -0.28, Fairly Valued between 9.20 and -0.28, Overvalued between 9.20 and 13.94, and Strongly Overvalued above 13.94. The current Forward P/OCF of 10.56 falls within the Overvalued range.
18.17
P/FCF
Phibro Animal Health Corp. (PAHC) has a current P/FCF of 18.17. The 5-year average P/FCF is 8.81. The thresholds are as follows: Strongly Undervalued below -6.67, Undervalued between -6.67 and 1.07, Fairly Valued between 16.56 and 1.07, Overvalued between 16.56 and 24.30, and Strongly Overvalued above 24.30. The current Forward P/FCF of 18.17 falls within the Overvalued range.
Phibro Animal Health Corp (PAHC) has a current Price-to-Book (P/B) ratio of 5.38. Compared to its 3-year average P/B ratio of 2.93 , the current P/B ratio is approximately 83.62% higher. Relative to its 5-year average P/B ratio of 3.20, the current P/B ratio is about 68.34% higher. Phibro Animal Health Corp (PAHC) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 0.69%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 0.73% , the current FCF yield is about -100.00% lower.
5.30
P/B
Median3y
2.93
Median5y
3.20
2.04
FCF Yield
Median3y
0.69
Median5y
0.73
Competitors Valuation Multiple
The average P/S ratio for PAHC's competitors is 0.00, providing a benchmark for relative valuation. Phibro Animal Health Corp Corp (PAHC) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 39.73%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of PAHC increased by 95.12% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 2.68 to 7.29.
The secondary factor is the Revenue Growth, contributed 39.73%to the performance.
Overall, the performance of PAHC in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is Phibro Animal Health Corp (PAHC) currently overvalued or undervalued?
What is Phibro Animal Health Corp (PAHC) fair value?
How does PAHC's valuation metrics compare to the industry average?
What is the current P/B ratio for Phibro Animal Health Corp (PAHC) as of Dec 05 2025?
What is the current FCF Yield for Phibro Animal Health Corp (PAHC) as of Dec 05 2025?
What is the current Forward P/E ratio for Phibro Animal Health Corp (PAHC) as of Dec 05 2025?